MedPath

BERIPLEX P/N 1000

BERIPLEX P/N 1000

Approved
DIN Number

02410826

Drug Class

Human

Market Date

Nov 21, 2013

Company
HC

csl behring canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02410826
AIG Number0652205004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD01 COAGULATION FACTOR IX, II, VII AND X IN COMB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (6)

COAGULATION FACTOR II (HUMAN)Active
Strength: 1600 UNIT
Monograph: COAGULATION FACTOR II (HUMAN)
COAGULATION FACTOR IX (HUMAN)Active
Strength: 1240 UNIT
Monograph: COAGULATION FACTOR IX (HUMAN)
COAGULATION FACTOR VII (HUMAN)Active
Strength: 1000 UNIT
Monograph: COAGULATION FACTOR VII (HUMAN)
COAGULATION FACTOR X (HUMAN)Active
Strength: 2040 UNIT
Monograph: COAGULATION FACTOR X (HUMAN)
PROTEIN CActive
Strength: 1640 UNIT
Monograph: PROTEIN C
PROTEIN SActive
Strength: 1360 UNIT
Monograph: PROTEIN S

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.